|
|
Autism Speaks, Science, Latest Research
Memantine Study to Target Motor Dysfunction in Autism ... data, a randomized multi-center clinical trial of memantine is warranted. ...
memantine.com - Clincial Studies
... Studies. Clinical studies with ... New Memantine Literature. Brief Profile. Product characteristics. Mode of Action ... Clinical Studies of Axura. AxuraВ® ...
Namenda (Memantine), Alzheimer's medication
Namenda (Memantine)is a medication used in the treatment of Alzheimer's. ... of 18 mg/kg/day in a study in which rats were given oral memantine beginning pre ...
"Memantine Study" from Glaucoma Associates of Texas
A team approach diagnoses rare types of glaucoma and unusual conditions. Early glaucoma ... 10mg of oral memantine each day, or treatment with placebo (the ...
Memantine
Memantine Helped Keep Autonomous: In a 28-week DB PC study of 252 adults with ... A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke ...
Information about Studies at memantine.com
Memantine.com | Studies: Here you get information about forms of diseases, drugs, therapies, care and latest research results.
Buy Memantine (Ebixa) - Optimal Health Products
Buy Memantine (Ebixa) online - 50 x 10 mg tablets Memantine - brand name Ebixa is a novel new drug that is showing a ... the study stated that; "Memantine was ...
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's ...
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease ... participated in an investigational study of neramexane, memantine, or amantadine. ...
Anti-Amyloid Therapies
... to moderate. Alzheimer's. In one study, participants taking memantine ... In two other studies. memantine failed to show any statistically significant benefit ...
Namenda (Memantine HCL) Drug Information: Uses, Side Effects, Drug ...
Learn about the prescription medication Namenda (Memantine HCL), drug uses, dosage, side effects, drug ... of 18 mg/kg/day in a study in which rats ...
|
|
|
|
Study of memantine |
Study of Memantine Augmentation in Severe Obsessive-Compulsive Disorder - Full Text View - ClinicalTrials.govMemantine is a glutamate receptor antagonist that has been reported to reduce Obsessive-Compulsive Disorder (OCD) symptoms in case studies of treatment-resistant individuals. The investigators hypothesized that memantine is an effective augmenting agent to standard intensive residential treatment of severe OCD. An intent-to-treat, single-blinded, naturalistic case-control design is employed. The sample includes subjects receiving standard treatment at the McLean/ MGH Intensive Residential Treatment (IRT) program, half of whom also receive memantine augmentation. Admission, monthly and discharge measures of OCD, depression and psychosocial functioning are collected by raters blinded to augmentation status. Matched controls are selected based upon gender, initial OCD severity, psychosocial functioning, and timing of admission.
|
Rating: 3.5 из 5 (голосов: 151) |
|
4 january 2008
Александр Новиков
|
|
|
|
|
memantine medication
memantine 10 mg
memantine prescribing information
of memantine hcl
|
|
|
|
|
CATIE-AD: Atypical Antipsychotics Linked to Weight Gain in Older Women
Medscape - Apr 23, 2009
At randomization, 46% were using antihypertensive agents, 60% were taking a cholinesterase inhibitor or memantine, 24% were on cholesterol-lowering ...
Forest Laboratories, Inc Q1 2009 Earnings Call Transcript
Seeking Alpha - Apr 21, 2009
The NDA for memantine ER is completed and waiting in the wings as we continue to monitor the patent litigation activities around Namenda. ...
FRX
Big Idea, Small Detail: Health, Money and Work
Reader's Digest - Apr 14, 2009
Multiyear studies at Harvard University and the University of Pittsburgh show that the drug memantine may have a valuable role in treating the disease. ...
Forest Under Fire
Psychiatric Times - Apr 8, 2009
The complaint also accused Forest of deceiving physicians by promoting the results of a positive study on pediatric use of citalopram,1 while failing to ...
FRX
Non-drug Treatment Of Alzheimer's Disease? Long-term Benefit Not ...
Science Daily (press release) - Apr 15, 2009
None of the 33 studies compared a non-drug intervention with a drug intervention assessed by IQWiG (cholinesterase inhibitors, ginkgo compounds, memantine). ...
Is Big Food the next Big Tobacco?
6minutes - Apr 15, 2009
Similarly memantine in dementia is just a minor tweak on the old drug amantadine, and there are no studies ion low glutamate diets in dementia. ...
|
|
|
|
|